QPS adopts Oracle Argus to advance safety in clinical trials
The integration of Oracle Argus enables QPS to better capture, manage, and report adverse events for regulatory requirements.
News
Axsome begins Phase III AXS-14 FORWARD trial for fibromyalgia management
AbCellera begins Phase II ABCL635 trial for menopause-related VMS
Marea reports positive Phase I results for MAR002 trial in acromegaly
BMS reports positive results in Phase III SCOUT-HCM trial for oHCM
Chemspec Europe Returns to Cologne in May 2026
UK introduces clinical trial regulatory reforms to enhance research appeal
MRM Health receives FDA clearance for STARFISH-UC Phase IIb trial
